| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 01/06/2010 | EP2140884A1 A vaccine preventing and/or treating autoimmune diseases |
| 01/06/2010 | EP2140880A1 Modification of allergens |
| 01/06/2010 | EP2139994A2 2786, a human aminopeptidase |
| 01/06/2010 | EP2139919A2 Human anti-ip-10 antibodies and uses thereof |
| 01/06/2010 | EP2139894A1 9-substituted-8-oxo-adenine compounds as toll-like receptor (tlr7) modulators |
| 01/06/2010 | EP2139865A1 Solid forms of (e) -1- (4- ( (ir, 2s, 3r) -1, 2, 3, 4-tetrahydroxybutyl) -1h-imidazol-2-yl) ethanone oxime |
| 01/06/2010 | EP2139524A1 Multivalent heterobifunctional polymers and methods of their use |
| 01/06/2010 | EP1032417B1 Bacterial vaccines comprising auxotrophic, attenuated strains of listeria expressing heterologous antigens |
| 01/06/2010 | EP0963197B1 Guanylhydrazones useful for treating diseases associated with t cell activation |
| 01/06/2010 | CN100577804C Novel mutant allergens |
| 01/06/2010 | CN100577790C Methods for the production of 3-O-deactivated-4'-monophosphoryl lipid A(3D-MLA) |
| 01/06/2010 | CN100577681C Compounds, compositions and methods for treatment of inflammatory diseases and conditions |
| 01/06/2010 | CN100577210C Drug delivery system based on immune response system |
| 01/06/2010 | CN100577206C Controlled release composition and method of producing the same |
| 01/06/2010 | CN100577199C Application of stomachic pill with cyperus and amomum |
| 01/06/2010 | CN100577182C Emulsion containing aucklandia root oil, its preparation process and use |
| 01/06/2010 | CN100577181C Extraction of herbs by heating alcohol |
| 01/06/2010 | CN100577170C Application of pyrazolopyrimidine Src family tyrosine kinase inhibitor in preparing medicament for curing myocardial infarction |
| 01/05/2010 | US7642903 Trailer tire alert system |
| 01/05/2010 | US7642351 2,4-Pyrimidinediamine compounds and their uses |
| 01/05/2010 | US7642290 Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection |
| 01/05/2010 | US7642276 N-[4-methyl-3-(3-piperidin-4-yl-1,2-benzisoxazol-6-yl)phenyl]-2-pyrrolidin-1-ylisonicotinamide; rheumatoid arthritis |
| 01/05/2010 | US7642243 Administering C-type natriuretic peptide, guanyl cyclase (GC-B)-activating peptide |
| 01/05/2010 | US7642081 Lactic acid bacteria and their cellular components inducing immunoregulatory function, and method of obtaining the same |
| 01/05/2010 | US7641909 Nonstructural and nonstructural proteins from attenuated dengue-2 virus, and structural protein from West Nile virus; vaccines |
| 01/05/2010 | US7641901 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 01/05/2010 | US7641895 Peptides for active anti-cytokine immunization |
| 01/05/2010 | US7641894 Stimulating neutrophil function to treat inflammatory bowel disease |
| 01/05/2010 | CA2545999C 1,2-di(cyclic)substituted benzene compounds |
| 01/05/2010 | CA2473503C Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
| 01/05/2010 | CA2465723C Process for reacting alkaloids and use of the reaction products in the preparation of medicaments |
| 01/05/2010 | CA2456183C Il-6/ds-sil-6r fusion protein |
| 01/05/2010 | CA2426457C Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 01/05/2010 | CA2405796C Methods and compositions for modulating alpha adrenergic receptor activity |
| 01/05/2010 | CA2392081C Pharmaceutically active isoindoline derivatives |
| 01/05/2010 | CA2332642C Method for producing or enhancing a t-cell response against a target cell using a complex comprising an hla class i molecule and an attaching means |
| 01/05/2010 | CA2185397C Arylalkyl-diazinones |
| 01/05/2010 | CA2175375C Glucosamine disaccharides, method for their preparation, pharmaceutical composition comprising same, and their use |
| 01/05/2010 | CA2062763C Cytokine synthesis inhibitory factor, antagonists thereof, and methods of using same |
| 12/31/2009 | US20090326206 Single-chain Multiple Antigen-binding Molecule, Its Preparation and Use |
| 12/31/2009 | US20090326038 Method for treating a immunology-related disease |
| 12/31/2009 | US20090326026 Tricyclic Compounds Useful as Angiotensin II Agonists |
| 12/31/2009 | US20090325988 Glucocorticoid Mimetics, Methods of Making Them, Pharmaceutical Compositions and Uses Thereof |
| 12/31/2009 | US20090325986 Deazapurine Analogs of 1'-Aza-L-Nucleosides |
| 12/31/2009 | US20090325982 Phosphodiesterase 4 inhibitors |
| 12/31/2009 | US20090325962 Tyrosine derivative |
| 12/31/2009 | US20090325952 Pyrazolo[3,4-b]pyridine compounds, and their use as pde4 inhibitors |
| 12/31/2009 | US20090325933 Pyrimidinone Derivatives and Their Use as a Drug |
| 12/31/2009 | US20090325927 Benzofuro- and benzothienopyrimidine modulators of the histamine H4 receptor |
| 12/31/2009 | US20090325896 Partial and full agonists of a1 adenosine receptors |
| 12/31/2009 | US20090325880 Tnf receptor-like molecules and uses thereof |
| 12/31/2009 | US20090324759 Immune enhancement by seed oil and/or seed flour |
| 12/31/2009 | US20090324723 Method of prophylaxis of infection |
| 12/31/2009 | US20090324651 Methods for Stimulating an Immune Response Using Bacterial Antigen Delivery System |
| 12/31/2009 | US20090324650 Method for The Production of Hydrolyzed Allergen |
| 12/31/2009 | US20090324646 Targeting the Histone Code as a Bacterial Strategy for Selectively Modulating Gene Expression |
| 12/31/2009 | US20090324640 Neuraminidase-deficient live influenza vaccines |
| 12/31/2009 | US20090324639 Compositions and methods for activating innate and allergic immunity |
| 12/31/2009 | US20090324632 Methods and reagents for vaccination which generate a CD8 T cell immune response |
| 12/31/2009 | US20090324628 Compounds useful in the diagnosis and treatment of malaria |
| 12/31/2009 | US20090324619 Immunogenic Protein Carrier Containing An Antigen Presenting Cell Binding Domain and A Cysteine-Rich Domain |
| 12/31/2009 | US20090324615 Methods and compositions for modulating t cell and/or b cell activation |
| 12/31/2009 | US20090324614 Fc receptor binding proteins |
| 12/31/2009 | US20090324599 activates FGF receptors, regulates the growth and differentiation of cells within the liver, regulates other cell types following secretion from the liver, plays a role in liver chemotaxis, has an oncogenic activity, or serves as an antigen for generating antibodies; treating diabetes or obesity |
| 12/31/2009 | US20090324598 Method for the treatment of inflammatory disorders |
| 12/31/2009 | US20090324575 Lysosomal phospholipase a2 (lpla2) activity as a diagnostic and therapeutic target for identifying and treating systemic lupus erythematosis |
| 12/31/2009 | US20090324557 Method to induce and expand therapeutic alloantigen-specific human regulatory t cells in large-scale |
| 12/31/2009 | US20090324545 Polymorphic forms of (s)-1-tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl)phenyl)ureido)benzyl carbamate |
| 12/31/2009 | US20090324512 Polypeptide constructs for nasal administration |
| 12/31/2009 | US20090324501 Vaccine Carrier |
| 12/31/2009 | DE102008031040A1 Use of 2-aminopyrimidine derivatives for the treatment of organ transplantation |
| 12/31/2009 | DE102008031039A1 Use of N-phenylquinazolin-4-amine derivatives as receptor tyrosine kinase inhibitor for accompanying treatment of organ transplantations |
| 12/31/2009 | DE102008031038A1 Use of 2-indolinone derivatives for the treatment of organ transplantation |
| 12/31/2009 | DE102008031037A1 Use of 2-aminopyrimidine derivatives as receptor tyrosine kinase inhibitor for accompanying treatment of organ transplantations |
| 12/31/2009 | DE102008031036A1 Use of 4-aminothiazolpyrimidine derivatives for the treatment of associated organ transplants |
| 12/31/2009 | DE102008031035A1 Use of urea derivatives as receptor tyrosine kinase inhibitor for accompanying treatment of organ transplantations |
| 12/30/2009 | WO2009158682A2 Compositions and methods for diagnosing and treating pathogenic disorders |
| 12/30/2009 | WO2009158571A1 Heteroaryl compounds and uses thereof |
| 12/30/2009 | WO2009158284A2 Methods and materials for producing immune responses against polypeptides involved in antibiotic resistance |
| 12/30/2009 | WO2009158031A2 Methods and compositions for therapeutic treatment |
| 12/30/2009 | WO2009158026A1 Hydrazonamide compounds that modulate hsp90 activity |
| 12/30/2009 | WO2009157886A1 Antitumoral, antioxidant and immunomodulatory composite agent |
| 12/30/2009 | WO2009157858A1 Use of cyclolignans for the treatment of a hyperactive immune system |
| 12/30/2009 | WO2009157802A1 Strain of a реniсilliuм vеrruсоsuм fungus for producing agent exhibiting immunomodulating properties and an immunomodulator agent based thereon |
| 12/30/2009 | WO2009157767A1 Nutritional composition for improving the mammalian immune system |
| 12/30/2009 | WO2009157759A1 Nutritional composition for improving the mammalian immune system |
| 12/30/2009 | WO2009157515A1 Pharmaceutical compositions |
| 12/30/2009 | WO2009157409A1 Innate immune activation composition with enhanced plant-derived innate immune activation effect |
| 12/30/2009 | WO2009156100A1 Substituted isoquinolines and isoquinolinones as rho kinase inhibitors |
| 12/30/2009 | WO2009156092A2 Bi- and polycyclic substituted isoquinoline and isoquinolinone derivatives |
| 12/30/2009 | WO2009155730A1 A pharmaceutical composition for treating disease caused by immune disturbance and the extract from tuckahoe |
| 12/30/2009 | WO2009124353A8 Modified cpn10 and prr signalling |
| 12/30/2009 | WO2009117831A9 Hybrid molecules having mixed vitamin d receptor agonism and histone deacetylase inhibitory properties |
| 12/30/2009 | WO2008140335A3 Methods of immune or hematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer, cancer symptoms, or the symptoms of cancer treatments |
| 12/30/2009 | EP2138482A1 Bicyclic heterocyclic compound |
| 12/30/2009 | EP2137146A1 Crystalline forms of atorvastatin 4-(nitrooxy) butyl ester |
| 12/30/2009 | EP1487444B1 Use of pyridyl amides as inhibitors of angiogenesis |
| 12/30/2009 | EP1470239B1 Psoriasin expression by breast epithelial cells |
| 12/30/2009 | CN101612402A Interferon antagonist and use of Flt3L interferon |
| 12/30/2009 | CN100575482C Novel cytokine zcytor17 ligand |